ABSTRACT
The integration of pharmaceutics, materials science, and nanotechnology has prompted the maturation of sophisticated drug delivery devices, among which liposomes have been extensively investigated. For several years of research activities in diverse fields, including drug delivery, biotechnology, pharmacology, cell therapy, nanotechnology, and nanomedicine, researchers have speculated on the conceptualization of small composite structures that perform physiological functions on demand. It is widely accepted that optimum treatment of a disease requires the availability of suitable drugs which can be delivered to desired targets without any toxic side effects. Various types of liposomes have been used as carriers for drugs, enzymes, proteins, peptides, toxins, and other bioactive materials. The pharmaceutical and biotechnology industries have been focusing on the design and manufacturing of advanced drug delivery systems. The solubilization and delivery of hydrophobic drugs utilizing a hydrophobic particle core would help circumvent comparable undesirable reactions or side effects.
